MAP1LC3B and cancer: Naringenin, also tentatively identified in this sub-fraction, has shown an inhibitory effect on human AGS cancer cells by activating autophagic proteins Beclin 1 and LC3B, with significant phosphorylation of mitogen-activated protein kinases (MAPKs) [49].